Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real-world practice

Uchikawa, S; Kawaoka, T; Aikata, H; Kodama, K; Nishida, Y; Inagaki, Y; Hatooka, M; Morio, K; Nakahara, T; Murakami, E; Hiramatsu, A; Tsuge, M; Imamura, M; Kawakami, Y; Chayama, K

Aikata, H (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Div Frontier Med Sci,Programs Biomed Res,Minami K, 1-2-3 Kasumi, Hiroshima 7348551, Japan.

HEPATOLOGY RESEARCH, 2018; 48 (10): 814

Abstract

AimAs second-line therapy, regorafenib has been shown to provide a survival benefit for patients with hepatocellular carcinoma (HCC) who progress on s......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索